Intech Biopharm Corporation

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

96

Website

www.intechbiopharm.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2010Taipei, Taiwan

Intech Biopharm develops and manufactures generic drugs to treat respiratory diseases in Taiwan and globally. The company offers combinations, formulations, and generic drugs for the treatment of respiratory diseases using technology platforms, such as inhaled low ethanol formulation, a metered dose inhaler platform for treating asthma and COPD

Dry powder inhaler that comprises blisters and capsules. Its products include SYN006, SYN010, SYN007, Synflutide, Duasma,Synvent, and SYN011. Founded in 2010, the company is headquartered in Taipei, Taiwan.

Key Stats

52-Week Range

NT$14.10NT$26.25

Beta0.15

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-2.57

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.